Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 88,099 | 71,876 | 68,147 | 100,589 | 49,661 |
| Cost of Goods | 70,446 | 61,210 | 56,648 | 81,863 | 46,453 |
| Gross Profit | 17,653 | 10,666 | 11,499 | 18,726 | 3,208 |
| Operating Expenses | 12,444 | 6,607 | 4,216 | 6,732 | 1,818 |
| Operating Income | 5,209 | 4,059 | 7,283 | 11,993 | 1,390 |
| Interest Expense | 294 | 776 | 674 | N/A | N/A |
| Other Income | -3,249 | 0 | -10,571 | -1,059 | 357 |
| Pre-tax Income | 1,666 | 3,282 | -3,962 | 10,934 | 1,747 |
| Income Tax | 2,400 | 729 | 1,679 | 3,339 | 437 |
| Net Income Continuous | -734 | 2,554 | -5,641 | 7,595 | 1,310 |
| Net Income | $-734 | $2,554 | $-5,641 | $7,595 | $1,310 |
| EPS Basic Total Ops | -0.03 | 0.11 | -0.22 | 0.33 | 0.06 |
| EPS Basic Continuous Ops | -0.03 | 0.11 | -0.22 | 0.33 | 0.06 |
| EPS Diluted Total Ops | -0.03 | 0.11 | -0.22 | 0.33 | 0.06 |
| EPS Diluted Continuous Ops | -0.03 | 0.11 | -0.22 | 0.33 | 0.06 |
| EBITDA(a) | $8,281 | $11,006 | $928 | $18,726 | $3,208 |